Top 50 Companies in Ophthalmology Contract Research Organization (CRO) Market: Key Insights and Innovations
RELEASE DATE: Aug 2025 Author: Spherical InsightsRequest Free Sample Speak to Analyst
Description
According to a research report published by Spherical Insights & Consulting, The Global Ophthalmology Contract Research Organization (CRO) Market Size is projected to Grow from USD 52.17 Billion in 2024 to USD 118.08 Billion by 2035, at a CAGR of 7.71% during the forecast period 2025–2035. The market for ophthalmology contract research organizations (CROs) is expanding rapidly due to both rising ocular disease rates and technology improvements. The increasing need for successful and economical clinical trials is the main reason why clinical trial management services are the best-performing market.
Introduction
Contract research organizations that specialize in ophthalmology provide full-service research and development assistance with an emphasis on ophthalmology medications, ophthalmic medical devices, and treatments. Pharmaceutical, biopharmaceutical, and medical device companies are among those that outsource these services. The primary drivers of the sector will be the rising incidence of eye disorders and the increased need for ophthalmic care. Companies can obtain specialist knowledge, cutting-edge technology, and modern facilities through outsourcing, which cuts down on the time and expenses involved in developing ophthalmic drugs, devices, and diagnostics internally. Additionally, more clinical trials are being carried out globally, and pharmaceutical companies are placing a greater focus on research and development in order to create new drugs.
Navigate Future Markets with Confidence: Insights from Spherical Insights LLP
The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Ophthalmology Contract Research Organization (CRO) Market.
Ophthalmology Contract Research Organization (CRO) Market Size & Statistics
- The Market Size for Ophthalmology Contract Research Organization (CRO) was Estimated to be Worth USD 52.17 Billion in 2024.
- The Market Size is Going to Expand at a CAGR of 7.71% between 2025 and 2035.
- The Global Ophthalmology Contract Research Organization (CRO) Market Size is Anticipated to Reach USD 118.08 Billion by 2035.
- North America is Expected to Generate the highest demand during the forecast period in the Ophthalmology contract research organization (CRO) market
- Asia Pacific is Expected to Grow the fastest during the forecast period in the Ophthalmology contract research organization (CRO) market.
Regional growth and demand
Asia Pacific is expected to grow the fastest during the forecast period in the Ophthalmology contract research organization (CRO) market. Ophthalmology CROs are finding that the Asia Pacific region is a profitable market. Healthcare industries that are expanding quickly in nations like China and India are crucial. These countries are establishing partnerships with international organizations and investing in cutting-edge research centers. Both rising disposable earnings and a greater understanding of ocular health are factors in the region's growth.
North America is expected to generate the highest demand during the forecast period in the Ophthalmology contract research organization (CRO) market. The market for contract research organizations (CROs) in ophthalmology is expanding significantly in a number of geographical areas. This market is dominated by North America, primarily because of its strong R&D efforts and sophisticated healthcare infrastructure. The region's market position is further strengthened by the existence of important industry players and a high frequency of ocular illnesses.
Top 10 trends in the Ophthalmology Contract Research Organization (CRO) Market
- Decentralized and virtual clinical trial models
- Rising adoption of AI-powered diagnostics and big data analytics
- Increased investment in R&D and precision medicine
- Growth in pediatric and rare ophthalmic disease research
- Globalization and expansion into emerging markets
- Advanced imaging and 3D retinal imaging technology
- Collaborative partnerships and mergers among CROs
- Outsourcing by new and mid-sized pharmaceutical/biotech companies
- Regulatory complexity and emphasis on quality compliance
- Increased venture capital and startup funding in eye health
1. Decentralized and virtual clinical trial models
Ophthalmology CROs are increasingly adopting decentralized and virtual trial platforms, which leverage digital tools to streamline data collection, patient engagement, and remote monitoring. This shift accelerates trial timelines, widens patient access (especially in geographically dispersed or underserved populations), and reduces operational costs, all while maintaining strong data integrity.
2. Rising adoption of AI-powered diagnostics and big data analytics
Artificial intelligence and advanced analytics now play a pivotal role in trial design, diagnostics, and real-time data management. AI tools enhance the identification of ocular pathologies, automate data analysis from imaging devices, and support decision-making, thus improving trial efficiency and outcomes for sponsors and CROs.
3. Increased investment in R&D and precision medicine
The market is witnessing major investment into ophthalmology R&D, particularly targeted therapies for specific genetic or molecular eye disorders. This push for precision medicine drives demand for specialist CROs with advanced capabilities in personalized trial design, biomarker identification, and stratified patient enrollment.
4. Growth in pediatric and rare ophthalmic disease research
There is an expanding focus on clinical research targeting pediatric and orphan ophthalmic diseases. As awareness and diagnosis improve, CROs are customizing protocols and trial logistics to address the unique needs of these populations, filling critical gaps in the development pipeline for underserved conditions.
5. Globalization and expansion into emerging markets
Leading CROs are expanding operations into emerging regions, driven by rising demand for ophthalmic care, rapidly growing patient pools, and government R&D incentives. This global outlook not only increases access to diverse patient populations but also shapes the market’s competitive landscape, attracting investment and enabling more cost-effective multi-center trials.
Empower your strategic planning:
Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the ophthalmology contract research organization (CRO) market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.
Top 25 Companies Leading the Ophthalmology Contract Research Organization (CRO) Market
- IQVIA Holdings Inc.
- Syneos Health
- Charles River Laboratories International Inc.
- Parexel International Corporation
- Iris Pharma
- Covance (Labcorp)
- PPD, Inc. (Thermo Fisher Scientific)
- ICON plc
- Medpace
- ICON Clinical Research
- ICON Medical Imaging
- PRA Health Sciences
- Chiltern (now part of Covance)
- SGS Life Sciences
- Novotech
- Celerion
- Synexus
- inVentiv Health Clinical
- Clinipace Worldwide
- Clinlogix
- ClinStar Clinical Research
- Veristat
- BioClinica, Inc.
- Worldwide Clinical Trials
- PharPoint Research
1. IQVIA Holdings Inc.
Headquarters: Durham, North Carolina, USA
IQVIA is a global leader in the Ophthalmology CRO market, known for combining deep clinical expertise with advanced analytics. Leveraging AI and machine learning, IQVIA optimizes the design, management, and analysis of ophthalmology clinical trials, supporting breakthrough therapies for conditions like macular degeneration and glaucoma. The company offers a full suite of services, from protocol development to regulatory consulting and post-marketing research, empowering pharmaceutical and biotech partners to navigate the complex eye health landscape. Strong global networks and robust, tech-enabled processes keep IQVIA at the forefront of ophthalmology innovation, driving reliable results for sponsors around the world.
2. Syneos Health
Headquarters: Morrisville, North Carolina, USA
Syneos Health demonstrates industry leadership through its dedicated ophthalmology division, which has delivered nearly 50 approved eye therapies and supported over 100 trials since 2016. Syneos leverages relationships with global research sites and a network of experienced investigators to ensure efficient site activation, patient recruitment, and data management. Its broad therapeutic range covers wet AMD, diabetic retinopathy, and rare ocular disorders, reinforced by regulatory expertise and operational agility. By uniting scientific knowledge and real-world insights, Syneos Health enables rapid development and commercialization of novel ophthalmology solutions.
3. Charles River Laboratories International Inc.
Headquarters: Wilmington, Massachusetts, USA
Charles River Laboratories is renowned for comprehensive ophthalmology CRO services, from preclinical safety studies to clinical development. Using state-of-the-art imaging and diagnostic platforms, Charles River supports a wide array of indications including gene therapy and regenerative eye treatments. The company partners closely with pharma, biotech, and device developers to streamline regulatory submission and accelerate the launch of innovative therapies. Its reputation is built on robust scientific rigor, experienced researchers, and tailored project strategies that address the unique complexities of eye health R&D.
4. Parexel International Corporation
Headquarters: Durham, North Carolina, USA
Parexel offers innovative solutions across all stages of ophthalmology drug and device development, mastering the regulatory and operational demands unique to eye health research. Parexel's ophthalmology team excels in adaptive trial design, quality compliance, and leveraging decentralized trial models to boost patient access and engagement. Through strategic global partnerships and KOL networks, Parexel enhances trial efficiency, mitigates risks, and pushes the frontiers of precision ophthalmology. Their insights help sponsors bring new sight-restoring therapies to market faster, especially in areas like inflammation and rare diseases.
5. Iris Pharma
Headquarters: La Gaude, France
Iris Pharma stands out as a specialized CRO focused exclusively on ophthalmology, offering comprehensive services spanning preclinical and clinical research phases. Renowned for bringing over 70 ocular therapies and devices to market in 34 years, Iris Pharma leverages deep expertise in diseases such as glaucoma, dry eye, and retinal disorders. The company leads in advanced imaging, international regulatory navigation, and customized project delivery. Their dedicated ophthalmology focus and holistic approach make Iris Pharma a trusted partner for sponsors aiming to advance the next generation of eye health solutions
Are you ready to discover more about the ophthalmology contract research organization (CRO) market?
The report provides an in-depth analysis of the leading companies operating in the global ophthalmology contract research organization (CRO) market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:
Company Profiles
- IQVIA Holdings Inc.
- Business Overview
- Company Snapshot
- Products Overview
- Company Market Share Analysis
- Company Coverage Portfolio
- Financial Analysis
- Recent Developments
- Merger and Acquisitions
- SWOT Analysis
- Syneos Health
- Charles River Laboratories International Inc.
- Parexel International Corporation
- Iris Pharma
- Covance (Labcorp)
- PPD, Inc. (Thermo Fisher Scientific)
- ICON plc
- Medpace
- Others.
Conclusion
The global ophthalmology contract research organization (CRO) market is set for robust growth driven by the increasing need for flexible, scalable, and secure digital infrastructure. Key trends such as AI and machine learning integration, multi-cloud strategies, edge computing, and enhanced cloud security are reshaping how businesses operate and innovate. The rapid expansion in regions like the Asia Pacific and the sustained demand in North America highlight diverse market opportunities. Leading companies like Amazon Web Services, Microsoft Azure, and Google Cloud continue to drive technological advancements and adoption globally. Staying aligned with these evolving trends and leveraging strategic insights will be critical for organizations aiming to capitalize on the lucrative and fast-evolving ophthalmology contract research organization (CRO) landscape.
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?